Chemical Compound

Allosamidin

CAS Registry Number 153322-50-0
Allosamidin chemical structure
Primary Record

Allosamidin

In stock
2,345 g
Purity
98.5 %
CAS
153322-50-0

Compound Identifiers & Properties

CAS
153322-50-0
PubChem CID
192630
SMILES
CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)NC(=O)C)O[C@@H]3[C@H]([C@H]4[C@@H]([C@H]3O)N=C(O4)N(C)C)CO)CO)CO)O)O
Canonical SMILES
CC(=O)N[C@H]1[C@H](O[C@H]2[C@H](O)[C@H]3N=C(N(C)C)O[C@H]3[C@@H]2CO)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2NC(C)=O)[C@@H]1O

Names & Synonyms

  • Allosamidin
  • AC1L4UNX
  • AC1Q5JNO
  • RefChem:160980
  • N,N'-Diacetylchitobiosyl allosamizoline
  • DTXSID80934733
  • MDWNFWDBQGOKNZ-SUAWCTRXSA-N
  • KST-1A2262
  • AR-1A3954
  • CID192630
  • N,N-Diacetylchitobiosyl allosamizoline
  • OD34921
  • 153322-50-0
  • J568.014J
  • N,N'-Diacetyl-beta-chitobiosyl allosamizoline
  • (3ar,4r,5r,6s,6as)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3ah-cyclopenta[d][1,3]oxazol-5-yl 2-(acetylamino)-4-o-[2-(acetylamino)-2-deoxy-|A-d-glucopyranosyl]-2-deoxy-|A-d-glucopyranoside
  • 1874-42-6
  • N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[[(3aR,4R,5R,6S,6aS)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazol-5-yl]oxy]-5-acetamido-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
  • (3aR,4R,5R,6S,6aS)-2-(Dimethylamino)-3a,5,6,6a-tetrahydro-4-hydroxy-6-(hydroxymethyl)-4H-cyclopentoxazol-5-yl 2-(acetylamino)-4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-deoxy-beta-D-glucopyranoside
  • (3aR,4R,5R,6S,6aS)-2-(Dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazol-5-yl 2-deoxy-4-O-{2-deoxy-2-[(1-hydroxyethylidene)amino]-beta-D-glucopyranosyl}-2-[(1-hydroxyethylidene)amino]-beta-D-glucopyranoside
  • [[(3aR)-2-(Dimethylamino)-3abeta,5,6,6abeta-tetrahydro-4beta-hydroxy-6beta-(hydroxymethyl)-4H-cyclopentoxazol]-5alpha-yl]2-(acetylamino)-4-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-deoxy-beta-D-glucopyranoside
  • 2-(Dimethylamino)-4-hydroxy-6-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopentoxazol-5-yl 2-acetamido-4-O-(2-acetamido-2-deoxyglucopyranosyl)-2-deoxyglucopyranoside
  • 2-(Dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazol-5-yl 2-deoxy-4-O-{2-deoxy-2-[(1-hydroxyethylidene)amino]hexopyranosyl}-2-[(1-hydroxyethylidene)amino]hexopyranoside
  • 5alpha-[4-O-[2-(Acetylamino)-2-deoxy-beta-D-glucopyranosyl]-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyloxy]-2-(dimethylamino)-6beta-(hydroxymethyl)-4,5,6,6abeta-tetrahydro-3abetaH-cyclopentaoxazole-4beta-ol
  • n-[(2r,3r,4r,5s,6r)-2-[[(3ar,4r,5r,6s,6as)-2-dimethylamino-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3ah-cyclopenta[d][1,3]oxazol-5-yl]oxy]-5-[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
  • N-[(2R,3R,4R,5S,6R)-2-{[(3aR,4R,5R,6S,6aS)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-3aH,4H,5H,6H,6aH-cyclopenta[d][1,3]oxazol-5-yl]oxy}-5-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
  • N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[[(3aR,4R,5R,6S,6aS)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazol-5-yl]oxy]-5-acetamido-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxa